{"text": "TITLE:\n      Supplemental Thyroxine Treatment for Preterm Infants With Hypothyroxinemia\nSUMMARY:\n      In order to determine the efficacy and safety of thyroxine replacement, a randomized\n      clinical trial of thyroxine supplementation for VLBW infant with hypothyroxinemia during the\n      first month of age is conducted.\nDETAILED DESCRIPTION:\n      A prospective randomized unmasked controlled trial is conducted. Newborn infants with birth\n      weight less than 1500g are randomized into thyroxine treatment or un-treatment group.\nELIGIBILITY CRITERIA:\n      Inclusion Criteria:\n          -  Birth weight: less than 1500g\n          -  Gestation: 22 weeks 0 day \u2264\n          -  Serum free thyroxine level lower than 0.8 ng/dl\n          -  Serum thyrotropin lower than 10 \u03bcU/ml\n          -  Age of between 2 and 4 weeks after birth\n          -  Informed consent\n        Exclusion Criteria:\n          -  any known thyroid disease in mother\n", "cuis": "C0040165 C0202231 C1281902 C0011824 C1881373 C2936885 C0087111 C1533734 C3887704 C0746919 C1947943 C1552616 C1706244 C0035139 C1555302 C0441587 C0040165 C0079691 C0202231 C1281902 C1522411 C3244315 C0242297 C0556088 C2935799 C2350507 C3537005 C1096775 C0040165 C0079691 C0202231 C1281902 C1561542 C0678257 C0033080 C1521941 C0204792 C2239178 C0005615 C1550722 C3245487 C0180112 C2911690 C0018792 C0040165 C0079691 C0202231 C1281902 C0087111 C3887704 C0376495 C1533734 C0746919 C0814472 C3647788 C0424653 C1305866 C2053618 C1552839 C0243161 C0013893 C0243161 C0424653 C1305866 C2053618 C0005615 C0032961 C1561538 C1269634 C0040160 C3536753 C0202230 C1535531 C3540791 C0229671 C1546774 C1550100 C0005615 C1550722 C3245487 C1114365 C0243161 C0040128 C2186538 C0030517 C0339143 C0237094 C0237133 C0237142 C0237155 C0237161 C0237162 C0237169 C0237178 C0237185 C0237206 C0237221 C0237228 C0237247 C0237255 C0237276 C0237283 C0237289 C0237305 C0237318 C0237324 C0237338 C0237357 C0237361 C0237369 C0237373 C0237380 C0237387 C1948167 C1948168 C1948169 C1948170 C1948171 C1948173 C1948174 C1948176 C1948178 C1948179 C1948180 C1948181 C3845898 ", "concepts": "thyroxine, Thyroxine, Thyroxine, D-Thyroxine, L-Thyroxine, l-Thyroxine, treatment, Treatment, treatment, No Treatment, Supplement summary, summary replacements, Replacement, placement, l thyroxine, L-thyroxine, Thyroxine, Thyroxine, Border, orders supplementation, Fat supplementation, DTS supplementation, Viscosupplementation, Iron supplementation, clinical trial, l thyroxine, L-thyroxine, Thyroxine, Thyroxine month description, prescription, prescription Newborn, Newborn, births, birth, birth, controllers, Controlled, Atrial l thyroxine, L-thyroxine, Thyroxine, Thyroxine, Treatment, treatment, Retreatment, Treatment, no treatment, co-treatment, maltreatment, weight, weight, weight, groups criteria, Eligibility Criteria weight, weight, weight, Birth Gestation, day Serum free thyroxine level Thyrotropin, thyrotropin, Thyrotropin, Thyrotropin, Thyrotropin, Serums, Serum, Serum births, birth, birth, Age Criteria thyroid diseases, thyroid disease, parathyroid diseases, eye thyroid disease, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, Uknown "}
